SCHEMBL20213967

SCHEMBL20213967

CC(N=[N+]=[N-])Oc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 4/20 0.38
▸ KDM4E B2RXH2 1/20 0.36
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ CA4 P22748 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ GAA P10253 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ CHRNB4 P30926 2/20 0.34
▸ CHRNA3 P32297 2/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ADRA2B P18089 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ NISCH Q9Y2I1 1/20 0.34
▸ ANPEP P15144 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374809 0.74 KDM4E (0.40) KDM4EMTNR1AMTNR1BCA4LMNA
SCHEMBL7973687 0.73 MTNR1A (0.40) KDM4EMTNR1AMTNR1BCA4LMNA
SCHEMBL9296320 0.69 KDM4E (0.47) KDM4EMTNR1AMTNR1BCA4LMNA
SCHEMBL22545038 0.68 LMNA (0.47) MTNR1AMTNR1BLMNACYP2C9CYP2C19
SCHEMBL18328138 0.68 PDE2A (0.58) PDE2AKDM4ELMNAGAAADRA2A
SCHEMBL22042123 0.68 PDE2A (0.58) PDE2AKDM4ELMNAGAAADRA2A
SCHEMBL13983512 0.68 PDE2A (0.58) PDE2AKDM4ELMNAGAAADRA2A
SCHEMBL5325563 0.68 MTNR1A (0.39) KDM4EMTNR1AMTNR1BCA4LMNA
SCHEMBL1453272 0.68 CA4 (0.48) KDM4EMTNR1AMTNR1BCA4LMNA
SCHEMBL12394 0.68 KMT2A (0.54) KDM4EMTNR1AMTNR1BCA4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018102006-A1 COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-06-07 — — WO disclosed
Send feedback